US Stock MarketDetailed Quotes

EBS Emergent BioSolutions

Watchlist
  • 4.740
  • -0.120-2.47%
Close Apr 1 16:00 ET
  • 4.654
  • -0.086-1.82%
Pre 09:07 ET
257.56MMarket Cap-1.32P/E (TTM)

About Emergent BioSolutions Company

Emergent BioSolutions Inc. engages in the development, manufacture, and commercialization of medical countermeasures. It offers products for civilian and military populations that address accidental, intentional, and naturally occurring public health threats. The firm's products include ACAM2000, BioThrax, Raxibacuma, Vaxchora, and VIGIV. Its business units include Vaccines and Anti-Infectives, Antibody Therapeutics, Devices, and Contract Development and Manufacturing. The company was founded by Fuad El-Hibri on September 5, 1998 and is headquartered in Gaithersburg, MD.

Company Profile

SymbolEBS
Company NameEmergent BioSolutions
Listing DateOct 2, 2009
Issue Price12.50
Founded1998
CEOMr. Joseph C. Papa
MarketNYSE
Employees900
Fiscal Year Ends12-31
Address300 Professional Drive,Suite 400
CityGaithersburg
ProvinceMaryland
CountryUnited States of America
Zip Code20879
Phone1-240-631-3200

Company Executives

  • Name
  • Position
  • Salary
  • Joseph C. Papa
  • Director, President and Chief Executive Officer
  • 5.86M
  • Simon C. Lowry, M.D.
  • Chief Medical Officer and Head of Research and Development
  • --
  • Richard S. Lindahl
  • Principal Accounting Officer, Executive Vice President, Chief Financial Officer and Treasurer
  • 2.31M
  • Jessica Perl
  • Senior Vice President, General Counsel and Corporate Secretary
  • --
  • Coleen Glessner
  • Executive Vice President, Quality and Ethics and Compliance
  • 2.05M
  • William Hartzel
  • Senior Vice President, Manufacturing and Bioservice
  • --
  • Paul Williams
  • Senior Vice President, Products Business
  • 1.68M
  • Dr. Zsolt Harsanyi,PhD
  • Chairman of the Board
  • 420.00K
  • Sujata Dayal
  • Independent Director
  • 275.00K
  • Ronald B. Richard
  • Independent Director
  • 275.00K
  • Neal F. Fowler
  • Independent Director
  • 270.00K
  • Marvin L. White
  • Independent Director
  • 290.00K
  • Keith A. Katkin
  • Independent Director
  • 285.00K
  • Donald W. DeGolyer
  • Independent Director
  • 265.00K
  • Dr. Louis W. Sullivan, M.D.
  • Independent Director
  • 275.00K
  • Dr. Kathryn C. Zoon, PhD
  • Independent Director
  • 285.00K

Market Insights

AI application software AI application software

AI application software stocks refer to companies that utilize advanced algorithms and computing capabilities in the field of artificial intelligence to develop and provide innovative software solutions. Through the application of artificial intelligence technology, these companies have improved the efficiency and functionality of their products to meet the needs of different industries, such as automation, data analysis, customer service, etc. AI application software stocks refer to companies that utilize advanced algorithms and computing capabilities in the field of artificial intelligence to develop and provide innovative software solutions. Through the application of artificial intelligence technology, these companies have improved the efficiency and functionality of their products to meet the needs of different industries, such as automation, data analysis, customer service, etc.

Unlock Now

Discussing

北水爆買!中國資產能否延續漲勢?
3月17日早盤,地產代理、物業服務及管理等板塊漲幅明顯,貝殼-W早盤漲逾4%,碧桂園服務漲逾9%。政策消息面上,兩部門發文落實專項債支持收地,中房協組織民營房企座談會。中國資產本輪火爆行情還能持續多久?你會如何投資? Show More

focus on technology stocks

Top tech company strong as always.